Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
ENGN

Updated 10/6/2026, 1:28 PM ET.

ENGN

enGene Therapeutics Inc.

Buy$10,051

Grossman William

Interim Chief Medical Officer, Director

5,102 shat $1.97Filed Sep 24, 4:40 PM ETFiling

Read from public SEC filings. Not financial advice.